β-thalassemia trait as a protective factor against alzheimer disease

Alzheimer Disease and Associated Disorders

Volumn 23, Issue 3, 2009, Pages 186-187

  Fallahzadeh, Mohammad Kazem ^b   Haghighi, Afshin Borhani ^a   Namazi, Mohammad Reza ^a   Fallahzadeh, Mohammad Hossein ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLOBIN; AMYLOID BETA PROTEIN; BETA GLOBIN; HEMOGLOBIN A; HEMOGLOBIN F; IMMUNOGLOBULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ALZHEIMER DISEASE; BETA THALASSEMIA; BLOOD BRAIN BARRIER; BLOOD VISCOSITY; BRAIN BLOOD FLOW; BRAIN INFARCTION; BRAIN PROTECTION; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DISEASE COURSE; DNA POLYMORPHISM; EDITORIAL; GLUCOSE UTILIZATION; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN SYNTHESIS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERHOMOCYSTEINEMIA; HYPERTENSION; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR;

ALZHEIMER DISEASE; BETA-THALASSEMIA; CEREBROVASCULAR CIRCULATION; FETAL HEMOGLOBIN; HUMANS; RISK FACTORS;

EID: 70349107281     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0b013e31819cb582     Document Type: Editorial

References (14)

1. Duron E, Hanon O. Vascular risk factors, cognitive decline, and dementia. Vasc Health Risk Manag. 2008;4:363-381.
2. Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci. 2004;5:347-360.
3. Schneider JA, Boyle PA, Arvanitakis Z, et al. Subcortical infarcts, Alzheimer's persons. Ann Neurol. 2007;62:59-66.
4. Girouard H, Iadecola C. Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease. J Appl Physiol. 2006;100:328-335.
5. Zlokovic BV, Deane R, Sallstrom J, et al. Neurovascular pathways and Alzheimer amyloid beta-peptide. Brain Pathol. 2005;15:78-83.
6. Chang CY, Liang HJ, Chow SY, et al. Hemorheological mechanisms in Alzheimer's disease. Microcirculation. 2007;14: 627-634.
7. Perry RT, Gearhart DA, Wiener HW, et al. Hemoglobin binding to a beta and HBG2 SNP association suggest a role in disease. Neurobiol Aging. 2008;29:185-193.
8. Karimi M, Haghighi AB, Yazdani M, et al. Is beta-thalassemia trait a protective factor against ischemic cerebrovascular accidents? J Stroke Cerebrovasc Dis. 2008;17:79-81.
9. Crowley JP, Sheth S, Capone RJ, et al. A paucity of thalassemia trait in Italian men with myocardial infarction. Acta Haematol. 1987;78:249-251.
10. Tassiopoulos S, Deftereos S, Konstantopoulos K, et al. Does heterozygous beta-thalassemia confer a protection against coronary artery disease? Ann NY Acad Sci. 2005;1054:467-470.
11. Gallerani M, Scapoli C, Cicognani I, et al. Thalassemia trait and disease. myocardial infarction: Low infarction incidence in male subjects confirmed. J Inter Med. 1991;230:109-111.
12. Maioli M, Pettinato S, Cherchi GM, et al. Plasma lipids in disease pathology, and memory function in older b-thalassemia minor. Atherosclerosis. 1989;75:245-248.
13. Fessas P, Stamatoyannopoulous G, Keys A. Serum cholesterol and thalassemia trait. Lancet. 1963;1:1182.
14. DeBaun MR, Vichinsky E. Hemoglobinopathies. In: Kliegman RM, Behrman RE, Jenson HB, et al, eds. Nelson Textbook of Pediatrics. .18th ed. Philadelphia, PA: Saunders; 2007: 2025-2038.